Microglia Diversity in Health and Multiple Sclerosis

Multiple Sclerosis (MS) is a neurodegenerative disease characterized by multiple focal lesions, ongoing demyelination and, for most people, a lack of remyelination. MS lesions are enriched with monocyte-derived macrophages and brain-resident microglia that, together, are likely responsible for much...

Full description

Bibliographic Details
Main Authors: Sameera Zia, Khalil S. Rawji, Nathan J. Michaels, Mena Burr, Bradley J. Kerr, Luke M. Healy, Jason R. Plemel
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2020.588021/full
_version_ 1819170060867993600
author Sameera Zia
Khalil S. Rawji
Nathan J. Michaels
Mena Burr
Bradley J. Kerr
Bradley J. Kerr
Luke M. Healy
Jason R. Plemel
Jason R. Plemel
author_facet Sameera Zia
Khalil S. Rawji
Nathan J. Michaels
Mena Burr
Bradley J. Kerr
Bradley J. Kerr
Luke M. Healy
Jason R. Plemel
Jason R. Plemel
author_sort Sameera Zia
collection DOAJ
description Multiple Sclerosis (MS) is a neurodegenerative disease characterized by multiple focal lesions, ongoing demyelination and, for most people, a lack of remyelination. MS lesions are enriched with monocyte-derived macrophages and brain-resident microglia that, together, are likely responsible for much of the immune-mediated neurotoxicity. However, microglia and macrophage also have documented neuroprotective and regenerative roles, suggesting a potential diversity in their functions. Linked with microglial functional diversity, they take on diverse phenotypes developmentally, regionally and across disease conditions. Advances in technologies such as single-cell RNA sequencing and mass cytometry of immune cells has led to dramatic developments in understanding the phenotypic changes of microglia and macrophages. This review highlights the origins of microglia, their heterogeneity throughout normal ageing and their contribution to pathology and repair, with a specific focus on autoimmunity and MS. As phenotype dictates function, the emerging heterogeneity of microglia and macrophage populations in MS offers new insights into the potential immune mechanisms that result in inflammation and regeneration.
first_indexed 2024-12-22T19:29:24Z
format Article
id doaj.art-7e764c1892a24efd8333c128f3e43c0f
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-22T19:29:24Z
publishDate 2020-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-7e764c1892a24efd8333c128f3e43c0f2022-12-21T18:15:09ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-11-011110.3389/fimmu.2020.588021588021Microglia Diversity in Health and Multiple SclerosisSameera Zia0Khalil S. Rawji1Nathan J. Michaels2Mena Burr3Bradley J. Kerr4Bradley J. Kerr5Luke M. Healy6Jason R. Plemel7Jason R. Plemel8Neuroscience and Mental Health Institute, University of Alberta, Edmonton, AB, CanadaWellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Campus, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United KingdomMinistry of Health, British Columbia Government, Victoria, BC, CanadaNeuroscience and Mental Health Institute, University of Alberta, Edmonton, AB, CanadaNeuroscience and Mental Health Institute, University of Alberta, Edmonton, AB, CanadaDepartment of Anesthesiology & Pain Medicine, University of Alberta, Edmonton, AB, CanadaNeuroimmunology Unit, Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, CanadaNeuroscience and Mental Health Institute, University of Alberta, Edmonton, AB, CanadaDepartment of Medicine, Division of Neurology, University of Alberta, Edmonton, AB, CanadaMultiple Sclerosis (MS) is a neurodegenerative disease characterized by multiple focal lesions, ongoing demyelination and, for most people, a lack of remyelination. MS lesions are enriched with monocyte-derived macrophages and brain-resident microglia that, together, are likely responsible for much of the immune-mediated neurotoxicity. However, microglia and macrophage also have documented neuroprotective and regenerative roles, suggesting a potential diversity in their functions. Linked with microglial functional diversity, they take on diverse phenotypes developmentally, regionally and across disease conditions. Advances in technologies such as single-cell RNA sequencing and mass cytometry of immune cells has led to dramatic developments in understanding the phenotypic changes of microglia and macrophages. This review highlights the origins of microglia, their heterogeneity throughout normal ageing and their contribution to pathology and repair, with a specific focus on autoimmunity and MS. As phenotype dictates function, the emerging heterogeneity of microglia and macrophage populations in MS offers new insights into the potential immune mechanisms that result in inflammation and regeneration.https://www.frontiersin.org/articles/10.3389/fimmu.2020.588021/fullmicrogliamacrophagessingle-cell analysissingle-cell RNA sequencingmultiple sclerosisremyelination
spellingShingle Sameera Zia
Khalil S. Rawji
Nathan J. Michaels
Mena Burr
Bradley J. Kerr
Bradley J. Kerr
Luke M. Healy
Jason R. Plemel
Jason R. Plemel
Microglia Diversity in Health and Multiple Sclerosis
Frontiers in Immunology
microglia
macrophages
single-cell analysis
single-cell RNA sequencing
multiple sclerosis
remyelination
title Microglia Diversity in Health and Multiple Sclerosis
title_full Microglia Diversity in Health and Multiple Sclerosis
title_fullStr Microglia Diversity in Health and Multiple Sclerosis
title_full_unstemmed Microglia Diversity in Health and Multiple Sclerosis
title_short Microglia Diversity in Health and Multiple Sclerosis
title_sort microglia diversity in health and multiple sclerosis
topic microglia
macrophages
single-cell analysis
single-cell RNA sequencing
multiple sclerosis
remyelination
url https://www.frontiersin.org/articles/10.3389/fimmu.2020.588021/full
work_keys_str_mv AT sameerazia microgliadiversityinhealthandmultiplesclerosis
AT khalilsrawji microgliadiversityinhealthandmultiplesclerosis
AT nathanjmichaels microgliadiversityinhealthandmultiplesclerosis
AT menaburr microgliadiversityinhealthandmultiplesclerosis
AT bradleyjkerr microgliadiversityinhealthandmultiplesclerosis
AT bradleyjkerr microgliadiversityinhealthandmultiplesclerosis
AT lukemhealy microgliadiversityinhealthandmultiplesclerosis
AT jasonrplemel microgliadiversityinhealthandmultiplesclerosis
AT jasonrplemel microgliadiversityinhealthandmultiplesclerosis